Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
By M. Costanzo, M. Guglin, M. Saltzberg, M. Jessup, B. Bart, J. Teerlink, B. Jaski, J. Fang, E. Feller, G. Haas and 3 more. Journal of the American College of Cardiology, 2007
983 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/2a73c6fa2528c31c4cf5cad72e6ba3559e8eec9d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- M. Gheorghiade
- G. Fonarow
- T. Horwich
- J. Cleland
- Gerasimos Filippatos
- J. Januzzi
- E. Braunwald
- S. Anker
In Nephrology
Citations in the corpus
- Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. (2007, neutral): “7) [24-94] 65.”
- Assessing and grading congestion in acute heart failure: a scientific statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine (2010, background): “Ultrafiltration appears to remove fluid and reduce hospitalizations; however, this fluid removal may or may not be associated with improved survival.(44)”
- Cardiorenal syndrome. (2008, positive): “f diuretic-resistant fluid overload exists despite an optiized cardiac output, removal of isotonic fluid can be chieved by the use of extracorporeal ultrafiltration (23,24).”
- 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “associated with refractory ventricular arrhythmias and a poor prognosis (161, 162).”